- Indexed In: Emerging Sources Citation Index (ESCI), Medline, PubMed, and Scopus
- Publication is subject to payment of an article processing charge (APC)
- Submit here
Journal of Evidence-Based Integrative Medicine (JEBIM) is a peer-reviewed open access journal which focuses on hypothesis-driven and evidence-based research in all fields integrative medicine. Please see the Aims and Scope tab for further information.
This journal is a member of the Committee on Publication Ethics (COPE).
Submit your manuscript today at http://mc.manuscriptcentral.com/JEBIM.
Please see the Submission Guidelines tab for more information on how to submit your article to the journal.
Open access article processing charge (APC) information
Publication in the journal is subject to payment of an article processing charge (APC). The APC serves to support the journal and ensures that articles are freely accessible online in perpetuity under a Creative Commons license.
The APC for this journal is currently $1200 USD.
The article processing charge (APC) is payable only if your article is accepted after peer review, before it is published. The APC is subject to taxes where applicable. Tax-exempt status can be indicated by providing appropriate registration numbers when payment is requested. Please see further details here.
Please direct any queries to firstname.lastname@example.org
This journal was previously known as Journal of Evidence-Based Complementary and Alternative Medicine (JEBCAM). It combined with Integrative Medicine Insights at the end of 2017.
Why Publish Open Access in JEBIM
- Visibility and Impact: Anyone anywhere in the world can read, use and cite your research
- Rigorous Standards: Double-blind peer review policy
- Flexibility: No page limits or page charges, and authors can publish full data sets, figures, tables, etc
- Copyright: Authors retain copyright under a Creative Commons License
- Contact the Editorial Office: email@example.com
The Journal of Evidence-Based Integrative Medicine (JEBIM) is an interdisciplinary, peer-reviewed, open access, biomedical journal whose aim is to create a global platform for hypothesis-driven and evidence-based research in all fields of integrative medicine.
JEBIM was created to be an invaluable resource for clinical researchers and scientists, physicians and other health practitioners, as well as graduate students on the trends, perspectives, and latest translational research in integrative medicine. The journal is currently accepting original research articles, research reviews, brief communications, correspondences, editorials, and book reviews. Please note that the journal rarely publishes case reports.
Topics include, but are not limited to:
- Complementary and alternative medicine (CAM)
- Traditional Eastern and Western medicine
- Nutrition therapy and supplementation
- Massage Therapy and Chiropractic medicine
- Non-traditional treatments
- Preventative medicine
- Integrative health and medicine
The journal accepts studies with both positive and negative outcomes.
Submit your manuscript at https://mc.manuscriptcentral.com/jebim
Please refer to the Submission Guidelines tab for more information before submitting your manuscript.
|Christa Walker||SAGE Publishing, USA|
|Donald I. Abrams||University of California, San Francisco, USA|
|Donald Patrick Albert, PhD||Sam Houston State University, USA|
|Thomas Arcury||Wake Forest University, USA|
|Julia T. Arnold, PhD||Bethesda, Maryland, USA|
|Ramesh Babu, MD||Central Council for Research in Ayurvedic Sciences, India|
|Ann Linda Baldwin||University of Arizona, USA|
|Marianna K. Baum||Robert Stempel College of Public Health and Social Work, Florida International University, Miami, Florida, USA|
|Catheryn Booth-LaForce||University of Washington, Seattle, USA|
|Carlo Calabrese, ND, MPH||Helfgott Research Institute, National College of Natural Medicine, USA|
|Changyi Chen||Baylor College of Medicine, USA|
|Lawrence J. Cheskin||John Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA|
|Ian D. Coulter||University of California, Los Angeles (UCLA), USA|
|J. Donald Dishman, DC, MSc||Palmer College, USA|
|Edzard Ernst, MD, PhD, FMed Sci, FSB, FRCP, FRCP(Edin)||Peninsula College of Medicine and Dentistry, United Kingdom|
|Patricia Evans, MD||University of Texas Southwestern Medical Center, USA|
|Muhammad Nabeel Ghayur||McMaster University, Canada|
|Christine L. Girard, ND||Southwest College of Naturopathic Medicine, USA|
|Melinda Goldner, PhD||Melinda Goldner, Union College, USA|
|Garry Gordon||Gordon Research Institute, USA|
|David Griesemer, MD||Levine Children's Hospital, Charlotte, NC, USA|
|Joerg Gruenwald, PhD||Analyze & Realize AG, Germany|
|Oliver Grundmann||University of Florida, USA|
|Ameenah Gurib-Fakim, PhD||University of Mauritius, the Republic of Mauritius|
|Mitchell Haas, DC, MA||University of Western States, USA|
|Andrew D. Halpner, PhD||Douglas Laboratories, USA|
|Melanie Henriksen, ND, LAc, CNM||National College of Natural Medicine, USA|
|Gary Hoff, DO||Des Moines University, USA|
|Randolph M. Howes, MD, PhD||Johns Hopkins Hospital, USA|
|Emily A. Kane, ND, LAc||Natural Healthcare, USA|
|Merrijoy Kelner||University of Toronto, Canada|
|Kathi J. Kemper, MD, MPH||Ohio State University, Columbus, OH, USA|
|Qisheng Li||National Institutes of Health, USA|
|Chenghai Liu||Shanghai University of Traditional Chinese Medicine, China|
|Tieraona Low Dog, MD||Professor Emeritus, University of Arizona College of Medicine, USA|
|Sheryl Martin, OMD, LAc, RN||Angela Kung Acupuncture Clinic, USA|
|Laurie Mischley, ND||Bastyr University, USA|
|Gerard E. Mullin||Johns Hopkins Hospital, USA|
|Delvac Oceandy||University of Manchester, UK|
|Tabatha Parker, ND||Natural Doctors International, Nicaragua|
|Kenneth R. Pelletier||University of Arizona School of Medicine, USA|
|Karen Pilkington, PhD||University of Westminster|
|Todd D. Porter, PhD||University of Kentucky, USA|
|Les Rose, BSc, CBiol, FSB, FICR, MAPM||Pharmavision Consulting Ltd, UK|
|Beverly Rubik||Institute for Frontier Science, USA|
|Bashar Saad, PhD||Al-Qasemi Academic College, Israel|
|Steven Sandberg-Lewis, ND||National College of Natural Medicine, USA|
|Dugald Seely, ND||Canadian College of Naturopathic Medicine, Canada|
|Zahoor Shah||University of Toledo, College of Pharmacy, USA|
|Rakesh Sharma||Florida State University, USA|
|Paul D. Terry, PhD, MPH||University of Tennessee, USA|
|Gail Tudor, PhD||Husson University, USA|
|Dana Ullman, MPH||Homeopathic Educational Services, California, USA|
|David C. Yang||Georgetown University, USA|
|Janice M. Zeller||North Park University, School of Nursing, USA|
|Guo-qing Zheng, PhD, MD||Wenzhou Medical College, Wenzhou, China|
This Journal is a member of the Committee on Publication Ethics.
This Journal recommends that authors follow the Recommendations for the Conduct, Reporting, Editing,
and Publication of Scholarly Work in Medical Journals formulated by the International Committee of
Medical Journal Editors (ICMJE).
Please read the guidelines below then visit the journal’s submission site
http://mc.manuscriptcentral.com/JEBIM to upload your manuscript. Please note that manuscripts not
conforming to these guidelines may be returned.
Only manuscripts of sufficient quality that meet the aims and scope of JEBIM will be reviewed.
As part of the submission process you will be required to warrant that you are submitting your original
work, that you have the rights in the work, that you are submitting the work for first publication in the
Journal and that it is not being considered for publication elsewhere and has not already been published
elsewhere, and that you have obtained and can supply all necessary permissions for the reproduction of
any copyright works not owned by you.
Please Read the Manuscript Submission Guidelines below before submitting your manuscript here:
- Open Access
- Article processing charge (APC)
- What do we publish?
3.1 Aims & scope
3.2 Article types
3.3 Writing your paper
3.3.1 Making your article discoverable
- Editorial policies
4.1 Peer Review Policy
4.3.1 Writing assistance
4.5 Declaration of conflicting interests
4.6 Research ethics and patient consent
4.7 Clinical Trials
4.8 Reporting guidelines
- Publishing policies
5.1 Publication ethics
5.1.2 Prior publication
5.2 Contributor's publishing agreement
- Preparing your manuscript
6.1 Word processing formats
6.2 Artwork, figures and other graphics
6.3 Supplementary material
6.4 Reference style
6.5 English language editing services
- Submitting your manuscript
7.1 How to submit your manuscript
7.2 Title, keywords and abstracts
7.2.1 Title page
7.2.4 Artwork submissions (Figures)
7.3 Information required for completing your submission
- On acceptance and publication
8.1 SAGE Production
8.2 Continuous publication
8.3 Promoting your article
- Further information
JEBIM is an open access, peer-reviewed journal. Each article accepted by peer review is made freely
available online immediately upon publication, is published under a Creative Commons license and will
be hosted online in perpetuity. Publication costs of the journal are covered by the collection of article
processing charges which are paid by the funder, institution or author of each manuscript upon
acceptance. There is no charge for submitting a paper to the journal.
If, after peer review, your manuscript is accepted for publication, a one-time article processing charge
(APC) is payable. This APC covers the cost of publication and ensures that your article will be freely
available online in perpetuity under a Creative Commons license.
An APC of $1,200 USD is payable upon acceptance.
Before submitting your manuscript to JEBIM, please ensure you have read the Aims & Scope.
All submissions (including invited material) are subjected to peer review. Authors are invited to
submit original articles of all types for consideration. The journal is currently accepting original
research articles, research reviews, brief communications, correspondences, editorials, and
Original Research: These are reports of original data and findings in a topic within the scope of
JEBIM. Original research must add to scientific knowledge on the subject and must be
completed in accordance with ethical principles. Research on humans or animals must have
applicable ethical approvals.
Research Reviews: Reviews should be a detailed examination of literature, which includes the
benefits, and drawbacks of a medicine, therapeutic technique, or anything else appropriate to
the journal. They are substantially composed of reports on previous research.
Brief Communications: This is a broad-scoped category for short papers discussing a topic
relevant to the journal.
Case reports can be submitted as brief communications. However, please note that case reports
are rarely published.
Correspondence: Letters to the editor can be submitted on any topic relevant to the journal and
are usually in response to an article published in the journal. They can suggest new subjects to
be incorporated by the journal or commend and review papers published in the journal. We
recommend that individuals considering submitting a letter to the editor should contact the
editor in chief first to discuss their manuscript. Authors should be aware that letters to the
editor are not always added to some databases/indexes.
Commentary: Commentaries are by invitation only. These are short summaries of significant
recent and forthcoming papers, published elsewhere, that provide additional insights, new
interpretations or speculation on the relevant topic. These manuscripts may include models,
which due to space limitations were not included or discussed in the original paper.
Commentaries may be written in free form, meaning that they do not need to be structured as a
research paper, however it must include an abstract of 150-200 words. They should be between
1000-2000 words and have no more than 25 references. Please include keywords for indexing
purposes. Figures are encouraged, but no more than three. Please give your commentary a brief
title and add the phrase “Comment on (citation to your original article).” underneath the
keywords. Commentary material may be peer reviewed at the editor’s discretion.
The SAGE Author Gateway has some general advice and on how to get published, plus links to
When writing up your paper, think about how you can make it discoverable. The title,
keywords and abstract are key to ensuring readers find your article through search
engines such as Google. For information and guidance on how best to title your article,
write your abstract and select your keywords, have a look at this page on the Gateway:
How to Help Readers Find Your Article Online
The journal’s policy is to have manuscripts reviewed by two expert reviewers. JEBIM utilizes a
double-blind peer review process in which the reviewer and authors’ names and information are
withheld from the other. All manuscripts are reviewed as rapidly as possible, while maintaining
rigor. Reviewers make comments to the author and recommendations to the Editor-in-Chief
who then makes the final decision.
The Editor or members of the Editorial Board may occasionally submit their own manuscripts for
possible publication in the journal. In these cases, the peer review process will be managed by
alternative members of the Board and the submitting Editor / Board member will have no
involvement in the decision-making process.
JEBIM is committed to delivering high quality, fast peer-review for your paper, and as such has
partnered with Publons. Publons is a third party service that seeks to track, verify and give credit
for peer review. Reviewers for JEBIM can opt in to Publons in order to claim their reviews or
have them automatically verified and added to their reviewer profile. Reviewers claiming credit
for their review will be associated with the relevant journal, but the article name, reviewer’s
decision and the content of their review is not published on the site. For more information visit
the Publons website.
Papers should only be submitted for consideration once consent is given by all contributing
authors. Those submitting papers should carefully check that all those whose work contributed
to the paper are acknowledged as contributing authors.
The list of authors should include all those who can legitimately claim authorship. This is all
(i) Made a substantial contribution to the concept or design of the work; or acquisition,
analysis or interpretation of data,
(ii) Drafted the article or revised it critically for important intellectual content,
(iii) Approved the version to be published,
(iv) Each author should have participated sufficiently in the work to take public
responsibility for appropriate portions of the content.
Authors should meet the conditions of all of the points above. Each author should have
participated sufficiently in the work to take public responsibility for appropriate portions of the
When a large, multicentre group has conducted the work, the group should identify the
individuals who accept direct responsibility for the manuscript. These individuals should fully
meet the criteria for authorship.
Acquisition of funding, collection of data, or general supervision of the research group alone
does not constitute authorship, although all contributors who do not meet the criteria for
authorship should be listed in the Acknowledgments section. Please refer to the International
Committee of Medical Journal Editors (ICMJE) authorship guidelines for more information on
All contributors who do not meet the criteria for authorship should be listed in an
Acknowledgements section as well as in the title page. Examples of those who might be
acknowledged include a person who provided purely technical help, or a department chair who
provided only general support.
Individuals who provided writing assistance, e.g. from a specialist communications company, do
not qualify as authors and so should be included in the Acknowledgements section. Authors
must disclose any writing assistance – including the individual’s name, company and level of
input – and identify the entity that paid for this assistance. It is not necessary to disclose use of
language polishing services.
Any acknowledgements should appear first at the end of your article prior to your Declaration of
Conflicting Interests (if applicable), any notes and your References.
Please supply any personal acknowledgements separately to the main text to facilitate
anonymous peer review.
JEBIM requires all authors to acknowledge their funding in a consistent fashion under a separate
heading. Please visit the Funding Acknowledgements page on the SAGE Journal Author Gateway
to confirm the format of the acknowledgment text in the event of funding, or state: “This
research received no specific grant from any funding agency in the public, commercial, or notfor-profit
It is the policy of JEBIM to require a declaration of conflicting interests from all authors enabling
a statement to be carried within the paginated pages of all published articles.
Please ensure that a ‘Declaration of Conflicting Interests’ statement is included both at the end
of your manuscript, after any acknowledgements and prior to the references as well as in your
title page. If no conflict exists, please state that ‘The Author(s) declare(s) that there is no conflict
For guidance on conflict of interest statements, please see the ICMJE recommendations.
Medical research involving human subjects must be conducted according to the World Medical
Association Declaration of Helsinki.
Submitted manuscripts should conform to the ICMJE Recommendations for the Conduct,
Reporting, Editing, and Publication of Scholarly Work in Medical Journals, and all papers
reporting animal and/or human studies must state in the methods section that the relevant
Ethics Committee or Institutional Review Board provided (or waived) approval. Please ensure
that you have provided the full name and institution of the review committee, in addition to the
For research articles, authors are also required to state in the methods section whether
participants provided informed consent and whether the consent was written or verbal.
Information on informed consent to report individual cases or case series should be included in
the manuscript text. A statement is required regarding whether written informed consent for
patient information and images to be published was provided by the patient(s) or a legally
Please also refer to the ICMJE Recommendations for the Protection of Research Participants.
All research involving animals submitted for publication must be approved by an ethics
committee with oversight of the facility in which the studies were conducted. The journal has
adopted the Consensus Author Guidelines on Animal Ethics and Welfare for Veterinary Journals
published by the International Association of Veterinary Editors.
JEBIM endorses the ICMJE requirement that clinical trials are registered in a WHO-approved
public trials registry at or before the time of first patient enrolment. However, consistent with
the AllTrials campaign, retrospectively registered trials will be considered if the justification for
late registration is acceptable. The trial registry name and URL, and registration number must be
included at the end of the abstract.
The relevant EQUATOR Network reporting guidelines should be followed depending on the type
of study. For example, all randomized controlled trials submitted for publication should include
a completed CONSORT flow chart as a cited figure and the completed CONSORT checklist should
be uploaded with your submission as a supplementary file. Systematic reviews and metaanalyses
should include the completed PRISMA flow chart as a cited figure and the completed
PRISMA checklist should be uploaded with your submission as a supplementary file. The
EQUATOR wizard can help you identify the appropriate guideline.
Other resources can be found at NLM’s Research Reporting Guidelines and Initiatives.
SAGE acknowledges the importance of research data availability as an integral part of the
research and verification process for academic journal articles.
JEBIM requests all authors submitting any primary data used in their research articles alongside
their article submissions to be published in the online version of the journal, or provide detailed
information in their articles on how the data can be obtained. This information should include
links to third-party data repositories or detailed contact information for third-party data
sources. Data available only on an author-maintained website will need to be loaded onto either
the journal’s platform or a third-party platform to ensure continuing accessibility. Examples of
data types include but are not limited to statistical data files, replication code, text files, audio
files, images, videos, appendices, and additional charts and graphs necessary to understand the
original research. The editor can also grant exceptions for data that cannot legally or ethically be
released. All data submitted should comply with Institutional or Ethical Review Board
requirements and applicable government regulations.
For further information, please contact the editorial office at firstname.lastname@example.org.
SAGE is committed to upholding the integrity of the academic record. We encourage authors to
refer to the Committee on Publication Ethics’ International Standards for Authors and view the
Publication Ethics page on the SAGE Author Gateway.
JEBIM and SAGE take issues of copyright infringement, plagiarism or other breaches of best
practice in publication very seriously. We seek to protect the rights of our authors and we
always investigate claims of plagiarism or misuse of published articles. Equally, we seek to
protect the reputation of the journal against malpractice. Submitted articles may be checked
with duplication-checking software. Where an article, for example, is found to have plagiarized
other work or included third-party copyright material without permission or with insufficient
acknowledgement, or where the authorship of the article is contested, we reserve the right to
take action including, but not limited to: publishing an erratum or corrigendum (correction);
retracting the article; taking up the matter with the head of department or dean of the author's
institution and/or relevant academic bodies or societies; or taking appropriate legal action.
If material has been previously published, it is not generally acceptable for publication in a SAGE
journal. However, there are certain circumstances where previously published material can be
considered for publication. Please refer to the guidance on the SAGE Author Gateway or if in
doubt, contact the Editor at the address given below.
Before publication SAGE requires the author as the rights holder to sign a Journal Contributor’s
Publishing Agreement. JEBIM publishes manuscripts under Creative Commons licenses. The
standard license for the journal is Creative Commons by Attribution Non-Commercial (CC BY-NC
3.0), which allows others to re-use the work without permission as long as the work is properly
referenced and the use is non-commercial. For more information, you are advised to visit SAGE's
OA licenses page.
Alternative license arrangements are available, for example, to meet particular funder
mandates, made at the author’s request.
The preferred format for your manuscript is Word, RTF, XLS. LaTeX files are also accepted. Word
and (La)Tex templates are available on the Manuscript Submission Guidelines page of our
For guidance on the preparation of illustrations, pictures and graphs in electronic format, please
visit SAGE’s Manuscript Submission Guidelines
Figures supplied in color will appear in color online.
This journal is able to host additional materials online (e.g. datasets, podcasts, videos, images
etc) alongside the full-text of the article. These will be subjected to peer-review alongside the
article. For more information please refer to our guidelines on submitting supplementary files,
which can be found within our Manuscript Submission Guidelines page.
JEBIM adheres to the AMA reference style. Please review the guidelines on AMA to ensure your
manuscript conforms to this reference style.
Authors seeking assistance with English language editing, translation, or figure and manuscript
formatting to fit the journal’s specifications should consider using SAGE Language Services. Visit
SAGE Language Services on our Journal Author Gateway for further information.
JEBIM is hosted on SAGE Track, a web based online submission and peer review system powered
by ScholarOne™ Manuscripts. Visit http://mc.manuscriptcentral.com/JEBIM to login and submit
your article online.
IMPORTANT: Please check whether you already have an account in the system before trying to
create a new one. If you have reviewed or authored for the journal in the past year it is likely
that you will have had an account created. For further guidance on submitting your manuscript
online please visit ScholarOne Online Help.
Please supply a title, short title, an abstract and keywords to accompany your article. Abstracts
need to be a minimum of 150 words. The title, keywords and abstract are key to ensuring
readers find your article online through online search engines such as Google. Please refer to
the information and guidance on how best to title your article, write your abstract and select
your keywords by visiting the SAGE Journal Author Gateway for guidelines on How to Help
Readers Find Your Article Online.
The title should be brief and meaningful. Following the title, there should be a listing of first and
last names of all authors, along with highest academic or medical degrees and affiliations.
Authorship should be limited to direct participants. List the complete name, postal address,
telephone number, fax number, and e-mail address for the corresponding author (authors who
do not have an e-mail account can obtain one from among the free sites such as “gmail.com,”
“hotmail.com,”' or “yahoo.com”'). List the word count for the manuscript [generally 7000 words
in a manuscript].
All manuscript submissions of any type must include disclosure sections in the title page. To be
complete, a response (even a negative response) is required in each disclosure section. The
sections that are required are: Acknowledgements, Author Contributions (Roles), Declaration of
Conflicting Interests, Funding (Financial Disclosure) and Ethical Approval.
An unstructured abstract of no less than 150 words should be provided on a separate page and
should be factual, presenting the reason for the study, main findings, and conclusions. A list of 3
to 5 keywords should be included at the end of the abstract.
The manuscript should be divided by subheadings (for example: introduction, methods, case
summary, results, and discussion). The hypothesis or reason for publication of the material must
be clearly described.
Artwork includes charts and graphs, maps, photographs, and line art. Electronic (computer
generated) art should be prepared as sharp, clear, high-quality computer images with a
minimum width of 2100 pixels and saved in uncompressed TIFF or JPEG file formats as grayscale
or CMYK images. Microsoft application files are acceptable for vector art (line art). Graphs
should be submitted as figure files and should be finished drawings, not requiring further
artwork (line art is preferable). All patient identifiers must be removed from pictures of
radiographs or other imaging modalities. Recognizable photographs of patients must be
accompanied by written permission for publication. Reproduction of any previously published
illustration must be accompanied by written permission from both the original author and the
publisher. Figure legends should include full explanations of the figures with numbers
corresponding to those on the figure files themselves. Abbreviations appearing in figures must
be fully identified in the legend. All figures must be specifically referred to in the text and
numbered in order of appearance in the text.
Each table should be prepared on a separate page at the end of the text document (after the
reference list) and preferably should be no larger than a single page. Include a brief descriptive
title of the table and a footnote with explanation of any abbreviations. All tables must be
specifically referred to in the text and numbered in order of appearance in the text.
Provide full contact details for the corresponding author including email, mailing address and
telephone numbers. Academic affiliations are required for all co-authors. These details should
be presented separately to the main text of the article to facilitate anonymous peer review.
You will be asked to provide contact details and academic affiliations for all co-authors via the
submission system and identify who is to be the corresponding author. These details must
match what appears on your manuscript. At this stage please ensure you have included all the
required statements and declarations and uploaded any additional supplementary files
(including reporting guidelines where relevant).
As part of our commitment to ensuring an ethical, transparent and fair peer review process
SAGE is a supporting member of ORCID, the Open Researcher and Contributor ID. ORCID
provides a persistent digital identifier that distinguishes researchers from every other researcher
and, through integration in key research workflows such as manuscript and grant submission,
supports automated linkages between researchers and their professional activities ensuring that
their work is recognized.
We encourage all authors to add their ORCIDs to their SAGE Track accounts and include their
ORCIDs as part of the submission process. If you don’t already have one you can create one
Authors are responsible for obtaining permission from copyright holders for reproducing any
illustrations, tables, figures or lengthy quotations previously published elsewhere. For further
information including guidance on fair dealing for criticism and review, please visit our
Frequently Asked Questions on the SAGE Journal Author Gateway.
If your paper is accepted for publication after peer review, you will first be asked to complete the
contributor’s publishing agreement. Once your manuscript files have been check for SAGE Production,
the corresponding author will be asked to pay the article processing charge (APC) via a payment link.
Once the APC has been processed, your article will be prepared for publication and can appear online
within an average of 30 days. Please note that no production work will occur on your paper until the
APC has been received.
Your SAGE Production Editor will keep you informed as to your article’s progress throughout the
production process. Proofs will be sent by PDF to the corresponding author and should be
returned promptly. Authors are reminded to check their proofs carefully to confirm that all
author information, including names, affiliations, sequence and contact details are correct, and
that Funding and Conflict of Interest statements, if any, are accurate. Please note that if there
are any changes to the author list at this stage all authors will be required to complete and sign
a form authorizing the change.
One of the many benefits of publishing your research in an open access journal is the speed to
publication. With no page count constraints, your article will be published online in a fully
citable form with a DOI number as soon as it has completed the production process. At this time
it will be completely free to view and download for all.
Publication is not the end of the process! You can help disseminate your paper and ensure it is
as widely read and cited as possible. The SAGE Author Gateway has numerous resources to help
you promote your work. Visit the Promote Your Article page on the Gateway for tips and advice.
In addition, SAGE is partnered with Kudos, a free service that allows authors to explain, enrich,
share, and measure the impact of their article. Find out how to maximize your article’s impact
Any correspondence, queries or additional requests for information on the Manuscript Submission
process should be sent to the JEBIM editorial office as follows: